An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces

Pharmaceutical Research

Volumn 25, Issue 2, 2008, Pages 337-348

  Jones, Matthew D ^a,c   Hooton, Jennifer C ^a,d   Dawson, Michelle L ^b   Ferrie, Alan R ^b   Price, Robert ^a  

^a University of Bath   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d ASTRAZENECA   (United Kingdom)

Author keywords

Adhesion; Agglomeration; Atomic force microscope; Fines; Ternary interactive mixture

Indexed keywords

ALPHA LACTOSE; BUDESONIDE; ERYTHRITOL; FLUTICASONE PROPIONATE; FORMOTEROL FUMARATE; LACTOHALE; LACTOSE; MANNITOL; SALMETEROL XINAFOATE; SORBOLAC 400; TREHALASE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; ATOMIC FORCE MICROSCOPY; DISPERSION; DRUG FORMULATION; DRY POWDER; INHALER; LASER DIFFRACTION; PARTICLE SIZE; PRIORITY JOURNAL;

ADHESIVENESS; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; MICROSCOPY, ATOMIC FORCE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS;

EID: 39149125793     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9467-1     Document Type: Article

References (42)

1. M. D. Jones and R. Price. The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm. Res. 23:1665-1674 (2006).
2. X. M. Zeng, G. P. Martin, S. K. Tee, A. Abu Ghoush, and C. Marriott. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. Int. J. Pharm. 182:133-144 (1999).
3. N. Islam, P. Stewart, I. Larson, and P. Hartley. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm. Res. 21:492-499 (2004).
4. H. Adi, P. Stewart, and I. Larson. Influence of different sugars on the dispersion of salmeterol xinafoate in dry powder inhalation formulations. Formula IV: Frontiers in Formulation Science. Royal Society of Chemistry, King's College, London, pp. O23 (2005).
5. H. Adi, I. Larson, and P. J. Stewart. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation. Int. J. Pharm. 337:229-238 (2007).
6. P. Lucas, K. Anderson, and J. N. Staniforth. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers. Pharm. Res. 15:562-569 (1998).
7. H. Adi, I. Larson, H. Chiou, P. M. Young, D. Traini, and P. Stewart. Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation. Pharm. Res. 23:2556-2565 (2006).
8. X. M. Zeng, G. P. Martin, C. Marriott, and J. Pritchard. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J. Pharm. Sci. 90:1424-1434 (2001).
9. X. M. Zeng, K. H. Pandhal, and G. P. Martin. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols. Int. J. Pharm. 197:41-52 (2000).
10. M. D. Louey, and P. J. Stewart. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm. Res. 19:1524-1531 (2002).
11. P. Begat, D. A. V. Morton, J. N. Staniforth, and R. Price. The cohesive-adhesive balances in dry powder inhaler formulations I: direct quantification by atomic force microscopy. Pharm. Res. 21:1591-1597 (2004).
12. M. Bunker, M. Davies, and C. Roberts. Towards screening of inhalation formulations: measuring interactions with atomic force microscopy. Expert Opin. Drug Del. 2:613-624 (2005).
13. P. Begat, D. A. V. Morton, J. N. Staniforth, and R. Price. The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics. Pharm. Res. 21:1826-1833 (2004).
14. P. Begat, R. Price, H. Harris, D. A. V. Morton, and J. N. Staniforth. The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations. KONA 23:109-121 (2005).
15. J. C. Hooton, M. D. Jones, and R. Price. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J. Pharm. Sci. 95:1288-1297 (2006).
16. D. El-Sabawi, R. Price, S. Edge, and P. M. Young. Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulation. Drug Dev. Ind. Pharm. 32:243-251 (2006).
17. F. R. Fronczek, H. N. Kamel, and M. Slattery. Three polymorphs (α, β and δ) of D-mannitol at 100 K. Acta Crystallogr., C Cryst. Struct. Commun. 59:567-570 (2003).
18. J. Albertsson, A. Oskarsson, and C. Svensson. X-ray study of budesonide: molecular structures and solid solutions of the (22S) and (22R) epimers of 11β,21-dihydroxy-16α,17α-propylmethylenedioxy-1, 4-pregnadiene-3,20-dione. Acta Crystallogr., B Struct. Sci. 34:3027-3036 (1978).
19. K. Jarring, T. Larsson, B. Stensland, and I. Ymen. Thermodynamic stability and crystal structures for polymorphs and solvates of formoterol fumarate. J. Pharm. Sci. 95:1144-1161 (2006).
20. B. Y. Shekunov, J. C. Feeley, A. H. L. Chow, H. H. Y. Tong, and P. York. Physical properties of supercritically-processed and micronised powders for respiratory drug delivery. KONA 20:178-187 (2002).
21. G. M. Brown, D. C. Rohrer, B. Berking, C. A. Beevers, R. O. Gould, and R. Simpson. The crystal structure of α,α-trehalose dihydrate from three independent X-ray determinations. Acta Crystallogr., B Struct. Sci. 28:3145-3158 (1972).
22. S. L. Raghavan, R. I. Ristic, D. B. Sheen, J. N. Sherwood, L. Trowbridge, and P. York. Morphology of crystals of α-lactose hydrate grown from aqueous solution. J. Phys. Chem. B 104:12256-12262 (2000).
23. C. Ceccarelli, G. A. Jeffrey, and R. K. McMullan. A neutron-diffraction refinement of the crystal structure of erythritol at 22.6 K. Acta Crystallogr. B Struct. Sci. 36:3079-3083 (1980).
24. GlaxoSmithKline. Crystal structure of fluticasone propionate (form 1) (unpublished data).
25. P. M. Young, R. Price, M. J. Tobyn, M. Buttrum, and F. Dey. Investigation into the effect of humidity on drug-drug interactions using the atomic force microscope. J. Pharm. Sci. 92:815-822 (2003).
26. F. E. M. O'Brien. The control of humidity by saturated salt solutions. J. Sci. Instrum. 25:73-76 (1948).
27. V. A. Marple, B. A. Olson, K. Santhanakrishnan, J. P. Mitchell, S. C. Murray, and B. L. Hudson-Curtis. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration. J. Aerosol Med. 16:301-324 (2003).
28. A. H. de Boer, D. Gjaltema, P. Hagedoorn, M. Schaller, W. Witt, and H. W. Frijlink. Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int. J. Pharm. 249:233-245 (2002).
29. H. W. Frijlink, and A. H. de Boer. Dry powder inhalers for pulmonary drug delivery. Expert Opin. Drug Del. 1:67-86 (2004).
30. J. C. Hooton, M. D. Jones, and R. Price. The effect of the use of a cohesive drug when predicting performance of dry powder inhalation formulations through the cohesive adhesive balance technique, Proceedings of Drug Delivery to the Lungs 16, The Aerosol Society, Edinburgh, UK, pp. 143-146 (2005).
31. H. Steckel, and N. Bolzen. Alternative sugars as potential carriers for dry powder inhalations. Int. J. Pharm. 270:297-306 (2004).
32. T. Hartmann and H. Steckel. Influence of mixer type and mixing conditions on delivery efficiency from Flowcaps, a capsule-based dry powder inhaler, Proceedings of Drug Delivery To The Lungs 15, The Aerosol Society, London, UK, pp. 178-181 (2004).
33. J. D. Lord and J. N. Staniforth. Particle size effects on packing and dispersion of powders. In R. N. Dalby, P. R. Byron, and S. J. Farr (eds.), Respiratory Drug Delivery V (R. N. Dalby, P. R. Byron, and S. J. Farr, eds). Interpharm Press Inc., pp. 75-84 (1996).
34. A. H. Ibrahim, P. F. Dunn, and R. M. Brach. Microparticle detachment from surfaces exposed to turbulent air flow: controlled experiments and modeling. J. Aerosol. Sci. 34:765-782 (2003).
35. D. A. Braaten, K. T. Paw, and R. H. Shaw. Particle resuspension in a turbulent boundary-layer observed and modeled. J. Aerosol. Sci. 21:613-628 (1990).
36. C. I. Fairchild, and M. I. Tillery. Wind-tunnel measurements of the resuspension of ideal particles. Atmos. Environ. 16:229-238 (1982).
37. A. H. Ibrahim, P. F. Dunn, and R. M. Brach. Microparticle detachment from surfaces exposed to turbulent air flow: effects of flow and particle deposition characteristics. J. Aerosol. Sci. 35:805-821 (2004).
38. W. John. Particle-surface interactions: charge transfer, energy loss, resuspension, and deagglomeration. Aerosol Sci. Technol. 23:2-24 (1995).
39. W. John, D. N. Fritter, and W. Winklmayr. Resuspension induced by impacting particles. J. Aerosol. Sci. 22:723-736 (1991).
40. W. John, and V. Sethi. Threshold for resuspension by particle impaction. Aerosol Sci. Technol. 19:69-79 (1993).
41. W. Theerachaisupakij, S. Matsusaka, Y. Akashi, and H. Masuda. Reentrainment of deposited particles by drag and aerosol collision. J. Aerosol. Sci. 34:261-274 (2003).
42. J. P. Mitchell, and M. W. Nagel. Particle size analysis of aerosols from medicinal inhalers. KONA 22:32-65 (2004).